CEO OWNS CULTIVATION OF CBD HEMP IN CALI ***READ**
Post# of 7775
Posted On: 01/13/2015 1:06:04 PM
CEO OWNS CULTIVATION OF CBD HEMP IN CALI ***READ****
Dr. Jones currently manages an off-grid, organic aquaponic fish, cannabis and whole plant production/cultivation in a very inhospitable desert climate in California. This system is focused on industrial hemp (IH) production of less than 0.3% Delta-9 THC/high CBD content. Per chromatograph analyses, our proprietary IH genetics of CBD:THC ratios range from 10:1 to 28:1 with THCA content of less than 0.3%, and “none detectable” on Delta-9 THC content. These strains are used for disease-specific clinical trials in conjunction with several universities throughout the United States. This company develops a complete, vertically integrated package of patentable genetics, cultivation techniques, extraction techniques, and delivery systems by range of wellness and category of human and animal disease.
As Director of Clinical Research for Phytosciences, Dr. Jones will lead a team consisting of formulation chemists, clinical trial research coordinators, cannabis product development specialists, and cannabis extraction analysts for the manufacturing and development of cannabis-based therapeutics. Dr. Jones collaborates with Dr. Akhilesh Kumar (Director of R & D) to coordinate cannabis product development to bring products to market.
Dr. Jones currently manages an off-grid, organic aquaponic fish, cannabis and whole plant production/cultivation in a very inhospitable desert climate in California. This system is focused on industrial hemp (IH) production of less than 0.3% Delta-9 THC/high CBD content. Per chromatograph analyses, our proprietary IH genetics of CBD:THC ratios range from 10:1 to 28:1 with THCA content of less than 0.3%, and “none detectable” on Delta-9 THC content. These strains are used for disease-specific clinical trials in conjunction with several universities throughout the United States. This company develops a complete, vertically integrated package of patentable genetics, cultivation techniques, extraction techniques, and delivery systems by range of wellness and category of human and animal disease.
As Director of Clinical Research for Phytosciences, Dr. Jones will lead a team consisting of formulation chemists, clinical trial research coordinators, cannabis product development specialists, and cannabis extraction analysts for the manufacturing and development of cannabis-based therapeutics. Dr. Jones collaborates with Dr. Akhilesh Kumar (Director of R & D) to coordinate cannabis product development to bring products to market.
(0)
(0)Green Cures & Botanical Distribution Inc. (GRCU) Stock Research Links
Scroll down for more posts ▼